Top Industry News

AbbVie has agreed to acquire ImmunoGen, a Waltham, Massachusetts-based bio/pharmaceutical company developing antibody drug conjugates (ADCs), for approximately $10.1 billion.  ImmunoGen’s commercial product is Elahere (mirvetuximab soravtansine-gynx), an ADC for…

Eli Lilly and Company has announced plans to construct a new $2.5-billion injectable manufacturing site in Alzey, Rhineland-Palatinate, Germany.   This new facility will further expand the company’s global parenteral (injectable)…

Novo Nordisk is investing DKK 16 billion ($2.3 billion) over the next four years to expand its production site in Chartres, France, for its current and future product portfolio within…

The latest from CDMOs, CMOs, and suppliers featuring Euroapi, Pharmathen, MilliporeSigma, Hovione, Batavia Biosciences, Hermes Pharma and Sohm.   Chemicals/Chemical API Manufacturing * Euroapi Acquires Oligo CDMO BianoGMPBiologics Manufacturing * Batavia Biosciences Opens…

A roundup of news from Amgen/Amazon, Merck & Co./Caraway Therapeutics, Bristol Myers Squibb/Avidity Biosciences, and Astellas/Propella Therapeutics. Highlights below.   Manufacturing News * Amgen, Amazon Partner for AI in Mfg Partnering * BMS, Avidity…

Novo Nordisk has announced an investment of more than DNK 42 billion ($6.1 billion) starting in 2023 to expand existing manufacturing facilities in Kalundborg, Denmark, for the company’s current and future…

Ajinomoto Co. has agreed to acquire Forge Biologics, an Ohio-based gene-therapy CDMO, for approximately $554 million.  The acquisition will be completed through Ajinomoto’s subsidiary, Ajinomoto North America Holdings, (ANH), and ANH…

The latest from CDMOs, CMOs, and suppliers featuring Vetter and Adragos Pharma.   Formulation Development/Drug Product Manufacturing * Vetter’s European Clinical Injectable Site Receives Permanent Manufacturer’s Authorization * Adragos Pharma Acquires Sterile Mfg…

A roundup of bio/pharmaceutical partnering news from Bayer/Recursion Pharma, Novartis/Legend Biotech and Gilead/Arcellx.  * Bayer, Recursion Pharma in $1.5-Bn Oncology Drug Research Pact* Novartis, Legend Biotech In $1.1-Bn CAR-T Licensing…

The latest from CDMOs, CMOs, and suppliers featuring Olon, BioCina, Noramco and Cambrex.   Chemicals/Chemical API Manufacturing * Olon To Invest $10.7 M to Expand India API Mfg Site  Biologics Manufacturing * BioCina,…